Related Experiment Videos
[In vivo testing of cell-mediated immunity in urology]
1Städtische Urologische Klinik Darmstadt, Frankfurt/M.
Onkologie
|June 1, 1987
Summary
The Multitest, a new skin test with 7 microbial antigens, showed a decrease in tumor spread and surgical complications in 558 patients. This test may help monitor cancer patients and identify those at higher risk.
Area of Science:
- Immunology
- Oncology
- Urology
Context:
- Assessing cellular immune response in urological patients.
- Evaluating novel diagnostic tools for cancer management.
Purpose:
- To investigate the efficacy of the Multitest in predicting tumor progression and perioperative complications.
- To determine the utility of a standardized microbial antigen test battery for risk stratification in urological cancer patients.
Summary:
- A disposable plastic device, the Multitest, containing 7 standardized microbial antigens, was used for skin testing in 558 urological patients and healthy individuals.
- Results demonstrated a statistically significant decrease in the generalization of tumor disease and perioperative complications.
- The study suggests the Multitest holds potential for monitoring cancer patients and identifying high-risk individuals.
Impact:
- The Multitest may offer a valuable tool for early detection and risk assessment in urological oncology.
- This standardized antigen test could improve patient outcomes by enabling proactive management strategies.
- Potential to enhance cancer patient monitoring and personalize perioperative care in urology.